Loading...
XETRRHK
Market cap968mUSD
Dec 23, Last price  
13.90EUR
1D
0.72%
1Q
10.32%
Jan 2017
-45.83%
Name

Rhoen Klinikum AG

Chart & Performance

D1W1MN
XETR:RHK chart
P/E
24.04
P/S
0.54
EPS
0.58
Div Yield, %
1.07%
Shrs. gr., 5y
—
Rev. gr., 5y
7.07%
Revenues
1.73b
+19.96%
1,044,753,0001,415,788,0001,933,043,0002,024,754,0002,130,277,0002,320,089,0002,550,384,0002,629,148,0002,864,909,0003,013,835,0001,510,519,0001,108,189,0001,176,349,0001,211,077,0001,232,908,0001,303,898,0001,360,159,0001,402,010,0001,446,086,0001,734,725,000
Net income
39m
+53.96%
76,404,00083,680,000105,200,000106,292,000122,644,000131,652,000145,069,000156,114,00089,685,00086,648,0001,225,711,00085,381,00056,430,00035,150,00048,993,00043,277,0002,463,00028,295,00025,144,00038,712,000
CFO
109m
+163.92%
167,100,000186,400,000235,600,000182,000,000187,000,000212,500,000221,500,000236,200,000139,100,000210,400,00049,200,00070,200,000109,100,00080,300,00049,500,00047,300,000113,300,00097,500,00041,300,000109,000,000
Dividend
Jun 08, 20230.15 EUR/sh
Earnings
Mar 26, 2025

Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
URL
https://www.rhoen-klinikum-ag.com/
IPO date
Nov 27, 1989
Employees
18,062
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,734,725
19.96%
1,446,086
3.14%
1,402,010
3.08%
Cost of revenue
1,536,650
468,262
450,595
Unusual Expense (Income)
NOPBT
198,075
977,824
951,415
NOPBT Margin
11.42%
67.62%
67.86%
Operating Taxes
7,562
6,689
(2,866)
Tax Rate
3.82%
0.68%
NOPAT
190,513
971,135
954,281
Net income
38,712
53.96%
25,144
-11.14%
28,295
1,048.80%
Dividends
(10,000)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,661
10,900
4,100
Long-term debt
153,276
155,800
165,864
Deferred revenue
24
(8,600)
(8,700)
Other long-term liabilities
8,360
15,128
11,841
Net debt
(199,182)
75,553
25,681
Cash flow
Cash from operating activities
109,000
41,300
97,500
CAPEX
(62,800)
(58,200)
(77,800)
Cash from investing activities
40,900
(86,200)
(58,300)
Cash from financing activities
(21,200)
(4,100)
(3,900)
FCF
200,993
939,892
956,078
Balance
Cash
342,842
304,934
299,716
Long term investments
13,277
(213,787)
(155,433)
Excess cash
269,383
18,843
74,182
Stockholders' equity
706,134
855,509
828,855
Invested Capital
1,169,040
1,372,513
1,284,924
ROIC
14.99%
73.09%
74.07%
ROCE
13.77%
69.85%
69.56%
EV
Common stock shares outstanding
66,938
66,938
66,938
Price
Market cap
EV
EBITDA
263,675
1,047,424
1,021,615
EV/EBITDA
Interest
3,700
4,100
3,200
Interest/NOPBT
1.87%
0.42%
0.34%